Profile data is unavailable for this security.
About the company
Allgens Medical Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of high-end biomedical materials and related medical device products. The Company’s main products are mineralized collagen artificial bone repair products used in orthopedics, oral or plastic surgery, and neurosurgery, including Gejin and BonGold, which are mainly used for filling and regenerative repair of various bone defects in the orthopedics field. Chibei, which are mainly used for filling and regenerating bone defects in oral and orthopedic surgery. And Lurui, which are mainly used for cranial defect filling and regeneration repair in neurosurgery. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in CNY (TTM)226.03m
- Net income in CNY42.66m
- Incorporated2004
- Employees202.00
- LocationAllgens Medical Technology Co Ltd#5 Kaituo RoadHaidian District, Room A305Beijing 102609ChinaCHN
- Phone+86 1 056330938
- Fax+86 1 056330939
- Websitehttp://www.allgensmed.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Nanfang Medical Co Ltd | 513.15m | -152.60m | 1.19bn | 858.00 | -- | 2.49 | -- | 2.31 | -0.5281 | -0.5281 | 1.77 | 1.63 | 0.3732 | 1.68 | 3.23 | 598,071.00 | -11.09 | -1.09 | -26.74 | -2.00 | 7.70 | 20.14 | -29.71 | -1.91 | 0.3585 | -12.20 | 0.5143 | -- | 10.03 | 4.57 | -906.35 | -- | -3.18 | -- |
| Thalys Medical Technology Group Corp | 2.05bn | -140.51m | 1.21bn | 1.41k | -- | 1.01 | -- | 0.590 | -0.8515 | -0.8515 | 11.25 | 5.97 | 0.5812 | 3.88 | 1.24 | 1,456,036.00 | -3.86 | -0.8933 | -7.08 | -1.62 | 19.24 | 22.12 | -6.63 | -1.49 | 1.47 | -1.09 | 0.4509 | -- | -13.10 | 8.77 | -2.69 | -- | -19.20 | -- |
| Touchstone International Medi Sci Co Ltd | 254.39m | 46.96m | 1.21bn | 243.00 | 23.84 | 2.11 | -- | 4.76 | 0.6264 | 0.6264 | 3.36 | 7.08 | 0.4371 | 3.37 | 28.08 | 1,046,885.00 | 8.07 | 10.09 | 8.66 | 10.82 | 55.49 | 57.59 | 18.46 | 20.17 | 9.45 | -- | 0.0031 | 24.66 | 9.31 | 16.34 | 9.53 | 15.39 | -2.39 | -- |
| HOB Biotech Group Corp Ltd | 399.23m | 45.58m | 1.44bn | 550.00 | 31.63 | 1.76 | -- | 3.61 | 0.7228 | 0.7228 | 6.33 | 12.97 | 0.4194 | 1.40 | 10.29 | 725,874.40 | 4.79 | 9.94 | 5.64 | 12.10 | 61.81 | 65.30 | 11.42 | 19.53 | 1.08 | -- | 0.0936 | 32.59 | 23.10 | 14.38 | 13.64 | 3.34 | 46.19 | -- |
| Guangzhou Jet Bio-Filtration Co Ltd | 487.09m | 51.76m | 1.47bn | 1.09k | 27.54 | 1.27 | -- | 3.02 | 0.3805 | 0.3805 | 3.62 | 8.26 | 0.3051 | 3.08 | 5.08 | 446,463.00 | 3.26 | 9.35 | 3.48 | 10.39 | 31.00 | 36.76 | 10.69 | 17.89 | 6.86 | 9.15 | 0.2319 | 29.64 | -24.06 | 17.42 | -60.34 | -8.02 | 47.32 | -- |
| Allgens Medical Technology Co Ltd | 226.03m | 42.66m | 1.69bn | 202.00 | 38.98 | 1.19 | -- | 7.48 | 0.3199 | 0.3199 | 1.70 | 10.47 | 0.151 | 1.42 | 3.98 | 1,118,950.00 | 2.78 | 7.62 | 2.90 | 8.30 | 80.57 | 83.60 | 18.40 | 39.05 | 35.91 | -- | 0.0354 | 5.25 | -7.68 | 12.86 | -43.04 | 10.46 | -26.12 | -- |
| Nanjing Medlander Medical Tech Co Ltd | 336.04m | 93.72m | 2.10bn | 481.00 | 22.45 | 1.52 | -- | 6.25 | 0.9354 | 0.9354 | 3.37 | 13.78 | 0.2194 | 1.88 | 18.91 | 698,624.50 | 6.35 | -- | 6.93 | -- | 73.32 | -- | 28.95 | -- | 8.63 | -- | 0.0104 | -- | -9.57 | -- | -26.19 | -- | -- | -- |
| Cowealth Medical China Co Ltd | 1.06bn | 45.10m | 2.20bn | 240.00 | 48.72 | 1.87 | -- | 2.07 | 0.1133 | 0.1133 | 2.67 | 2.95 | 0.7144 | 4.20 | 1.38 | 4,433,473.00 | 3.03 | 5.80 | 3.78 | 8.09 | 20.55 | 20.74 | 4.24 | 6.14 | 3.68 | -- | 0.0986 | 23.89 | -14.62 | 3.85 | -42.96 | -6.75 | 32.85 | -- |
Data as of Jun 07 2024. Currency figures normalised to Allgens Medical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 1.21m | 1.16% |
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 980.38k | 0.95% |
| Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 865.49k | 0.83% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 371.50k | 0.36% |
| Maxwealth Fund Management Co., Ltd.as of 31 Dec 2023 | 307.49k | 0.30% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 305.37k | 0.29% |
| Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 40.00k | 0.04% |
| CITIC Securities Co., Ltd. (Invt Port)as of 31 Dec 2023 | 23.97k | 0.02% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 23.61k | 0.02% |
| HFT Investment Management Co., Ltd.as of 31 Dec 2023 | 23.10k | 0.02% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
